GlobalData projects China's medical devices market to top US$42B in 2022, making up 8.3% global market; China expected to continue expanding its market due to aging population, tech improvements, development of clinic/hospital services in wake of pandemic

Sample article from our Health Care Sector

July 12, 2022 (press release) –

The medical devices market in China is expected to continue to expand due to the growing aging population, technological improvements, and the development of clinic and hospital services in the wake of the COVID-19 pandemic. Against this backdrop, the market value of key medical devices in China will surpass $42 billion in 2022, accounting for 8.3% of the global medical devices market, forecasts GlobalData, a leading data and analytics company.

Tina Deng, MSc, Principal Medical Devices Analyst at GlobalData, comments: “The pandemic has boosted the sales of medical devices related to COVID-19 prevention and management. Medical devices such as testing reagents, medical masks, medical protective gowns, ventilators, and infrared thermometers not only saw an increase in sales due to strong domestic demand, but also continued to expand their production and supply for customers overseas.”

Several COVID-19 testing companies have now raised enough funds to invest in the research and development of new in vitro diagnostic product lines. Additionally, the pandemic has accelerated the development of the medical infrastructure in tier-1 hospitals and clinics. Multiple government departments have issued guidelines to purchase advanced configurations of large medical equipment in 2021. Domestic devices are usually preferred over imported medical devices in the national or regional procurement.

Deng concludes: “Product innovation has become very important to achieve long-term success for device companies after the COVID-19 pandemic. New medical technologies continue to emerge. The development of digital healthcare has been accelerated in China during the pandemic.

“The application of new technologies, including artificial intelligence and big data, has shown signs of commercialization. Point-of-care testing, precision medicine, and wearable devices in the field of diagnosis and treatment have been used in clinical practice. These new technologies are important to the prevention, diagnosis, treatment, and prognosis of diseases, and will profoundly affect the development direction of the medical devices industry in China.”

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.